These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 2887995)

  • 1. Behavioral suppression following 3,4-methylenenedioxymethamphetamine.
    Kulmala HK; Boja JW; Schechter MD
    Life Sci; 1987 Sep; 41(11):1425-9. PubMed ID: 2887995
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of (+-)3,4-methylenedioxymethamphetamine (MDMA) on brain dopaminergic activity in rats.
    Matthews RT; Champney TH; Frye GD
    Pharmacol Biochem Behav; 1989 Aug; 33(4):741-7. PubMed ID: 2575758
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acute and subchronic effects of methylenedioxymethamphetamine [(+/-)MDMA] on locomotion and serotonin syndrome behavior in the rat.
    Spanos LJ; Yamamoto BK
    Pharmacol Biochem Behav; 1989 Apr; 32(4):835-40. PubMed ID: 2572003
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A role for the mesolimbic dopamine system in the psychostimulant actions of MDMA.
    Gold LH; Hubner CB; Koob GF
    Psychopharmacology (Berl); 1989; 99(1):40-7. PubMed ID: 2571175
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stimulant and hallucinogenic behavioral profiles of 3,4-methylenedioxymethamphetamine and N-ethyl-3,4-methylenedioxyamphetamine in rats.
    Gold LH; Koob GF; Geyer MA
    J Pharmacol Exp Ther; 1988 Nov; 247(2):547-55. PubMed ID: 2903234
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Methysergide potentiates the hyperactivity produced by MDMA in rats.
    Gold LH; Koob GF
    Pharmacol Biochem Behav; 1988 Mar; 29(3):645-8. PubMed ID: 2896363
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of optical isomers of 3,4-methylenedioxymethamphetamine (MDMA) on stereotyped behavior in rats.
    Hiramatsu M; Nabeshima T; Kameyama T; Maeda Y; Cho AK
    Pharmacol Biochem Behav; 1989 Jun; 33(2):343-7. PubMed ID: 2573077
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Psychostimulant properties of MDMA.
    Gold LH; Geyer MA; Koob GF
    NIDA Res Monogr; 1989; 95():345-6. PubMed ID: 2577038
    [No Abstract]   [Full Text] [Related]  

  • 9. Behavioral effects of (+-) 3,4-methylenedioxyamphetamine (MDA) and (+-) 3,4-methylenedioxymethamphetamine (MDMA) in the pigeon: interactions with noradrenergic and serotonergic systems.
    Nader MA; Hoffmann SM; Barrett JE
    Psychopharmacology (Berl); 1989; 98(2):183-8. PubMed ID: 2569215
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term central 5-HT depletions resulting from repeated administration of MDMA enhances the effects of single administration of MDMA on schedule-controlled behavior of rats.
    Li AA; Marek GJ; Vosmer G; Seiden LS
    Pharmacol Biochem Behav; 1989 Jul; 33(3):641-8. PubMed ID: 2573905
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discriminative stimulus properties of (+/-)-3,4-methylenedioxymethamphetamine and (+/-)-3,4-methylenedioxyamphetamine in pigeons.
    Evans SM; Johanson CE
    Drug Alcohol Depend; 1986 Oct; 18(2):159-64. PubMed ID: 2877843
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stimulant effects of 3,4-methylenedioxymethamphetamine in the nucleus accumbens of rat.
    Callaway CW; Geyer MA
    Eur J Pharmacol; 1992 Apr; 214(1):45-51. PubMed ID: 1349861
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of the behavioral and neurochemical effects of 5,7-DHT, MDMA and D,L-fenfluramine.
    Lorens SA; Hata N; Cabrera T; Hamilton ME
    NIDA Res Monogr; 1989; 95():347. PubMed ID: 2577039
    [No Abstract]   [Full Text] [Related]  

  • 14. The effects of 3,4-methylenedioxymethamphetamine (MDMA) and 3,4-methylenedioxyamphetamine (MDA) on monoaminergic systems in the rat brain.
    Stone DM; Stahl DC; Hanson GR; Gibb JW
    Eur J Pharmacol; 1986 Aug; 128(1-2):41-8. PubMed ID: 2875893
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stereochemical effects of 3,4-methylenedioxymethamphetamine (MDMA) and related amphetamine derivatives on inhibition of uptake of [3H]monoamines into synaptosomes from different regions of rat brain.
    Steele TD; Nichols DE; Yim GK
    Biochem Pharmacol; 1987 Jul; 36(14):2297-303. PubMed ID: 2886126
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of dopamine release by methylenedioxymethamphetamine is mediated by serotonin.
    Gazzara RA; Takeda H; Cho AK; Howard SG
    Eur J Pharmacol; 1989 Sep; 168(2):209-17. PubMed ID: 2575036
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The threshold lowering effects of MDMA (ecstasy) on brain-stimulation reward.
    Hubner CB; Bird M; Rassnick S; Kornetsky C
    Psychopharmacology (Berl); 1988; 95(1):49-51. PubMed ID: 2898790
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MDMA produces stimulant-like conditioned locomotor activity.
    Gold LH; Koob GF
    Psychopharmacology (Berl); 1989; 99(3):352-6. PubMed ID: 2574478
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stimulus properties of 1-(3,4-methylenedioxyphenyl)-2-aminopropane (MDA) analogs.
    Glennon RA; Yousif M; Patrick G
    Pharmacol Biochem Behav; 1988 Mar; 29(3):443-9. PubMed ID: 2896360
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discriminative profile of MDMA.
    Schechter MD
    Pharmacol Biochem Behav; 1986 Jun; 24(6):1533-7. PubMed ID: 2874566
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.